Roger Reig, Albert
Padró Casas, Clara
Gutiérrez Fernández, Diego
Orta Cuevas, José Carlos
Sánchez López, Germán
Corzo Higueras, José Luis
Funding for this research was provided by:
Stallergenes SAS
Article History
Accepted: 28 January 2021
First Online: 16 February 2021
Declarations
:
: This study was funded by Stallergenes SAS.
: Albert Roger Reig has received a grant for his participation as coordinator of the study, support for travel to meetings for the study and manuscript preparation and honorarium for writing and reviewing the manuscript from Stallergenes Greer; Clara Padró Casas has received support for travel to meetings for the study and consulting fees from Stallergenes Greer; Diego Gutiérrez Fernández has received honorarium for his participation in the study; José Carlos Orta Cuevas has received honorarium for his participation in the study; Germán Sánchez López has received honorarium for his participation in the study; José Luis Corzo Higueras has no conflicts of interest that are directly relevant to the content of this article.
: The study’s objectives and procedures were approved by an independent ethics committee (Clinical Research Ethics Committee, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain; approval reference number: EPA-14-050; approval date; 9 December, 2014) and registered with the Spanish regulatory authority (Agencia Española de Medicamentos y Productos Sanitarios).
: Before participation in the study, written informed consent was provided by each patient or (for under-age patients) by the patient’s parents or legal guardian.
: Not applicable.
: The authors declare that the data supporting the findings of this study are available within the article.
: Not applicable.
: All authors contributed to the study conception and design, material preparation, data collection and analysis. All authors read and approved the final manuscript.